Back to results
US 2025/0353821 A1Published application
Benzene sulfonamide thiazole compounds and their use for the treatment of cancers
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Université CôTe D'Azur, Biper Therapeutics SAS, Centre National De La Recherche Scientifique
InventorsStéphane ROCCHI, Mehdi CHELBI, Cyril RONCO, Rachid BENHIDA
Life of this patent
Estimating the term…
Abstract
The present inventors have shown that specific benzene sulfonamide thiazole compounds (I) have the ability to induce an early endoplasmic reticulum stress. These compounds also lead to cancerous cells growth inhibition and death.
Claims15
A benzene sulfonamide thiazole compound of formula (I):
- wherein
- R1 is a 5-(dimethylamino)naphthalene group or a 4-pentylphenyl group;
- R2 is selected from H, halogen;
- and OR6;
- R3 is selected from C1-C8 alkyl;
- and NR4R5;
- R4 is selected from H;
- and alkyl optionally substituted with a nitrogen-containing heterocycle;
- R5 is selected from H, alkyl optionally substituted with a nitrogen-containing heterocycle, and COR7;
- R4 and R5 alternatively form together a nitrogen-containing heterocycle which is optionally substituted;
- R6 is selected from C1-C8 alkyl and C1-C8 alkyl-O—C1-C8 alkyl,
- R7 is selected from
- C1-C8 alkyl optionally substituted with
- a nitrogen-containing heterocycle which is optionally substituted
- O-alkyl, NHCO-alkyl, NHCOO-alkyl, COO-alkyl, NH-alkyl, NH-alkyl-OH, NHP(O)(O-alkyl)2, NH-alkyl-SO3H, NH-alkyl-N(alkyl)2 and
- alkenyl.
13 more elements
Dependencies are inferred from the claim text.